0001237899-13-000051.txt : 20130920 0001237899-13-000051.hdr.sgml : 20130920 20130920162535 ACCESSION NUMBER: 0001237899-13-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130918 FILED AS OF DATE: 20130920 DATE AS OF CHANGE: 20130920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLEIFER LEONARD S CENTRAL INDEX KEY: 0001218629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 131108158 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-09-18 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001218629 SCHLEIFER LEONARD S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President & CEO Common Stock 2013-09-18 4 M 0 218389.0 9.49 A 260476 D Common Stock 2013-09-18 4 F 0 6808.0 304.38 D 253668 D Common Stock 2013-09-18 4 F 0 108632.0 304.38 D 145036 D Common Stock 2013-09-19 4 S 0 36334.0 300.33 D 108702 D Common Stock 2013-09-19 4 S 0 15611.0 301.45 D 93091 D Common Stock 2013-09-19 4 S 0 15625.0 302.68 D 77466 D Common Stock 2013-09-19 4 S 0 5103.0 303.38 D 72363 D Common Stock 2013-09-19 4 S 0 10645.0 304.36 D 61718 D Common Stock 2013-09-19 4 S 0 7026.0 305.5 D 54692 D Common Stock 2013-09-19 4 S 0 7248.0 306.47 D 47444 D Common Stock 2013-09-19 4 S 0 1157.0 307.2 D 46287 D Common Stock 2013-09-19 4 S 0 1200.0 308.7 D 45087 D Common Stock 2013-09-19 4 S 0 1200.0 309.8 D 43887 D Common Stock 2013-09-19 4 S 0 1800.0 310.14 D 42087 D Common Stock 5618 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 9.49 2013-09-18 4 M 0 218389.0 0.0 D 2014-12-15 Common Stock 218389 0 D Non-Qualified Stock Option (right to buy) 304.38 2013-09-18 4 A 0 6808.0 0.0 A 2014-03-18 2014-12-15 Common Stock 6808 6808 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 36,334 shares of Company stock on September 19, 2013 at prices ranging from $300.00 to $300.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 15,611 shares of Company stock on September 19, 2013 at prices ranging from $301.00 to $301.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 15,625 shares of Company stock on September 19, 2013 at prices ranging from $302.00 to $302.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 5,103 shares of Company stock on September 19, 2013 at prices ranging from $303.00 to $303.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 10,645 shares of Company stock on September 19, 2013 at prices ranging from $304.03 to $304.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 7,026 shares of Company stock on September 19, 2013 at prices ranging from $305.00 to $305.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 7,248 shares of Company stock on September 19, 2013 at prices ranging from $306.00 to $306.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 1,157 shares of Company stock on September 19, 2013 at prices ranging from $307.00 to $307.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 1,200 shares of Company stock on September 19, 2013 at prices ranging from $309.72 to $309.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 19, 2013 at prices ranging from $310.00 to $310.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Leonard S. Schleifer 2013-09-20